2019 Infectious Disease Diagnostics Market: Supplier Shares by Country and Strategic Assessments of Leading Suppliers

This new 795-page report from contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic Technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
 
Market Segmentation Analysis

- Review of five POC market segments, including their dynamics, trends, structure,
  size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for major infectious disease tests
  by market segment:

- Physician Offices/Group Practices    
- Emergency Rooms       
- Ambulatory Care Centers        
- Surgery Centers 
- Birth Centers

Sales and Market Share Analysis

- Market shares of major infectious disease diagnostic reagent and instrument suppliers.

Current and Emerging Products

- Analysis of infectious disease diagnostic tests performed in POC testing locations.
- Review of leading infectious disease testing analyzers, both currently marketed and
  those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging Technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing coagulation
   testing Technologies and products, by assay.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, joint ventures,
  and new products in R&D.

Strategic Recommendations

- Specific opportunities for new infectious disease testing instruments and reagent systems with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.

Methodology
This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and proprietary data files.


Current and Emerging Technologies

Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
0 Polymerase Chain Reaction
- Temperature Cyclers
- PCR Variations
0 Immuno-PCR
0 QC-PCR
0 DAP-PCR
0 Ligase Chain Reaction
0 Branched DNA
0 Q-Beta Replicase
0 Nucleic-Acid Sequence-Based
0 Strand Displacement Activation
Monoclonal Antibodies
Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
0 Overview
0 ELISA
0 Dot Immunobinding Assays
0 Capillary Immunoassays
0 Particle-Membrane Capture Immunoassays
0 Enzyme Amplification
c. Fluorescent Immunoassays
0 Fluorescence Polarization
0 Time-Resolved Pulse Fluorescence
d. Luminescence
0 Chemiluminescence
0 Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation

Differential Light Scattering
IT
Artificial Intelligence
Liposomes
Flow Cytometry
Chromatography
MRI
Gel Microdroplets
Other
Competitive Profiles
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical *6.
- Kreatech /HLFD


- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac 3(
- Wako

2020 Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular

USD 24500 View Report

2024 Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular

USD 24500 View Report

2024 US Hospital Infectious Disease Market Tests Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Technologies Instrumentation and Opportunities

2024 US Hospital Infectious Disease Market for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and OpportunitiesThis new report from contains 997 pages, 87

USD 4500 View Report

2024 UK Hospital Infectious Disease Market Tests Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Technologies Instrumentation and Opportunities

2024 UK Hospital Infectious Disease Market for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and OpportunitiesThis new report from contains 886 pages, 67

USD 4500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available